KR101227301B1 - 표정을 지을때 생기는 주름 및 노화성 주름에 대한 신규한국소 적용제 - Google Patents

표정을 지을때 생기는 주름 및 노화성 주름에 대한 신규한국소 적용제 Download PDF

Info

Publication number
KR101227301B1
KR101227301B1 KR1020077011046A KR20077011046A KR101227301B1 KR 101227301 B1 KR101227301 B1 KR 101227301B1 KR 1020077011046 A KR1020077011046 A KR 1020077011046A KR 20077011046 A KR20077011046 A KR 20077011046A KR 101227301 B1 KR101227301 B1 KR 101227301B1
Authority
KR
South Korea
Prior art keywords
acid
compound
benzyl
hydrogen
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020077011046A
Other languages
English (en)
Korean (ko)
Other versions
KR20070085372A (ko
Inventor
도미니크 임펠트
휴고 지글러
페테르 뷔크스트로엠
Original Assignee
디에스엠 아이피 어셋츠 비.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 디에스엠 아이피 어셋츠 비.브이. filed Critical 디에스엠 아이피 어셋츠 비.브이.
Publication of KR20070085372A publication Critical patent/KR20070085372A/ko
Application granted granted Critical
Publication of KR101227301B1 publication Critical patent/KR101227301B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
KR1020077011046A 2004-11-02 2005-11-01 표정을 지을때 생기는 주름 및 노화성 주름에 대한 신규한국소 적용제 Expired - Lifetime KR101227301B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH18092004 2004-11-02
CH1809/04 2004-11-02
PCT/CH2005/000638 WO2006047900A2 (de) 2004-11-02 2005-11-01 Neue topisch anwendbare wirkstoffe gegen mimische und alterabedingt falten

Publications (2)

Publication Number Publication Date
KR20070085372A KR20070085372A (ko) 2007-08-27
KR101227301B1 true KR101227301B1 (ko) 2013-01-29

Family

ID=35841896

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077011046A Expired - Lifetime KR101227301B1 (ko) 2004-11-02 2005-11-01 표정을 지을때 생기는 주름 및 노화성 주름에 대한 신규한국소 적용제

Country Status (12)

Country Link
US (1) US7964630B2 (enExample)
EP (1) EP1809652B1 (enExample)
JP (1) JP5006789B2 (enExample)
KR (1) KR101227301B1 (enExample)
CN (1) CN101061134B (enExample)
AT (1) ATE466867T1 (enExample)
BR (1) BRPI0517917B1 (enExample)
CA (1) CA2584643C (enExample)
DE (1) DE502005009544D1 (enExample)
ES (1) ES2345667T3 (enExample)
PL (1) PL1809652T3 (enExample)
WO (1) WO2006047900A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160084540A (ko) * 2015-01-05 2016-07-14 원광대학교산학협력단 올리고펩타이드 유도체 및 이를 포함하는 주름개선용 조성물
KR20180094980A (ko) * 2015-12-16 2018-08-24 디에스엠 아이피 어셋츠 비.브이. 신규한 용도

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100240977A1 (en) * 2007-06-20 2010-09-23 Andreas Caduff Method for measuring the response of a tissue to an electromagnetic field
AU2009215436A1 (en) 2008-02-19 2009-08-27 Myocept Inc. Postsynaptically targeted chemodenervation agents and their methods of use
WO2010003861A1 (en) * 2008-07-08 2010-01-14 Unilever Plc Antiperspirant products
EP2143418A1 (en) 2008-07-08 2010-01-13 Unilever PLC Antiperspirant compositions
EP2456457B1 (en) 2009-07-24 2014-10-22 Lipotec, S.A. Compounds which inhibit muscle contraction
JP4666537B1 (ja) * 2010-01-21 2011-04-06 株式会社資生堂 しわ改善用美容セット並びにこれを使用する美容方法
US10149812B2 (en) 2012-04-13 2018-12-11 Activen Cosmetic composition comprising a muconopeptide
ES2678793T3 (es) 2012-04-13 2018-08-17 Activen Composición cosmética que comprende un muconopéptido
RU2524428C1 (ru) * 2013-01-21 2014-07-27 Общество с ограниченной ответственностью "Синейро" Пептиды и их производные, взаимодействующие с никотиновым ацетилхолиновым рецептором и пригодные для использования в косметологии против мимических и возрастных морщин
CN103570804B (zh) * 2013-09-11 2015-04-15 深圳市维琪医药研发有限公司 一种具皮肤活性的多肽的合成方法
CA2928526A1 (en) 2013-11-01 2015-05-07 Spherium Biomed S.L. Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
RU2551276C1 (ru) * 2014-02-03 2015-05-20 Закрытое Акционерное Общество "Фарм-Синтез" Способ получения диацетата трипептида
US9649266B2 (en) * 2014-05-01 2017-05-16 Anterios, Inc. Methods to treat, prevent, and improve skin conditions
CN104327155A (zh) * 2014-10-20 2015-02-04 张嘎 一种含有15n—l—脯氨酸残基的三肽型减皱化合物及其制备方法和应用
CN104478991B (zh) * 2014-12-10 2018-06-19 深圳市维琪医药研发有限公司 一种新型多肽化合物及其制备方法和其医药应用
CN104592348A (zh) * 2015-01-16 2015-05-06 张嘎 一种含有3,4-脱氢-l-脯氨酸残基的三肽减皱化合物及其制备方法和应用
KR102706016B1 (ko) * 2015-12-16 2024-09-13 디에스엠 아이피 어셋츠 비.브이. 신규한 용도
CN112010772A (zh) * 2016-01-26 2020-12-01 赵鸣 5-氨基酮戊酸及其衍生物的盐化合物和应用
CN106038385A (zh) * 2016-06-08 2016-10-26 广州市创美时美容化妆品有限公司 一种刺激胶原蛋白生成抵抗皱纹的化妆品组合物
CN107936108A (zh) * 2017-12-05 2018-04-20 陕西慧康生物科技有限责任公司 一种类蛇毒三肽的液相合成方法
CN107857797A (zh) * 2017-12-07 2018-03-30 陕西慧康生物科技有限责任公司 一种类蛇毒三肽的液相片段合成方法
ES2937382T3 (es) 2018-02-27 2023-03-28 Lipotrue S L Péptidos y composiciones para uso en cosmética y medicina
KR102724873B1 (ko) * 2018-05-24 2024-11-04 디에스엠 아이피 어셋츠 비.브이. 프롤린 유도체의 신규한 용도
CN118561963A (zh) 2018-10-16 2024-08-30 格罗制药公司 烟碱乙酰胆碱受体肽拮抗剂芋螺毒素组合物及相关方法
CN113045623A (zh) * 2019-12-27 2021-06-29 深圳翰宇药业股份有限公司 一种蛇毒肽syn-ake的液相合成方法
CN110950926B (zh) * 2019-12-31 2020-10-16 山东济肽生物科技有限公司 类蛇毒三肽的液相合成方法
CN114369139B (zh) * 2020-10-14 2024-04-19 成都泰莱康科技有限公司 类蛇毒三肽的制备方法
US11771637B2 (en) 2021-01-22 2023-10-03 The Procter & Gamble Company Skin care composition and method of using the same
US11571378B2 (en) 2021-01-22 2023-02-07 The Procter & Gamble Company Skin care composition and method of using the same
CN113693964B (zh) * 2021-08-16 2023-03-24 深圳市维琪医药研发有限公司 肽衍生物在制备用于皮肤修复紧致的组合物中的新用途
CN114380887A (zh) * 2021-12-09 2022-04-22 深圳翰宇药业股份有限公司 一种类蛇毒三肽的液相片段合成方法
WO2025162944A2 (en) * 2024-01-29 2025-08-07 Dsm Ip Assets B.V. Novel compounds
WO2025170081A1 (en) 2024-02-05 2025-08-14 L'oreal Stabilization of composition comprising polyhydroxy acid, beta-hydroxy acid and peptide with polyol
FR3160325A3 (fr) 2024-03-19 2025-09-26 L'oreal Stabilisation d'une composition comprenant un polyhydroxyacide, un bêta-hydroxyacide et un peptide avec du polyol

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966701A (en) 1973-11-07 1976-06-29 The Dow Chemical Company Fibrinogen peptide derivatives
US4563305A (en) 1981-01-07 1986-01-07 University Of Miami Radiolabelled substrates for assaying mammalian enzymes
US6169074B1 (en) 1996-03-18 2001-01-02 The Regents Of The University Of California Peptide inhibitors of neurotransmitter secretion by neuronal cells
EP1180524A1 (en) * 1999-04-23 2002-02-20 Lipotec, S.A. Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7408027B1 (en) * 1991-12-06 2008-08-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenchaften Tools for the diagnosis and treatment of Alzheimer's disease

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966701A (en) 1973-11-07 1976-06-29 The Dow Chemical Company Fibrinogen peptide derivatives
US4563305A (en) 1981-01-07 1986-01-07 University Of Miami Radiolabelled substrates for assaying mammalian enzymes
US6169074B1 (en) 1996-03-18 2001-01-02 The Regents Of The University Of California Peptide inhibitors of neurotransmitter secretion by neuronal cells
EP1180524A1 (en) * 1999-04-23 2002-02-20 Lipotec, S.A. Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160084540A (ko) * 2015-01-05 2016-07-14 원광대학교산학협력단 올리고펩타이드 유도체 및 이를 포함하는 주름개선용 조성물
KR101710486B1 (ko) 2015-01-05 2017-02-28 주식회사 앤코스메슈 올리고펩타이드 유도체 및 이를 포함하는 주름개선용 조성물
KR20180094980A (ko) * 2015-12-16 2018-08-24 디에스엠 아이피 어셋츠 비.브이. 신규한 용도
KR102783075B1 (ko) * 2015-12-16 2025-03-19 디에스엠 아이피 어셋츠 비.브이. 신규한 용도

Also Published As

Publication number Publication date
KR20070085372A (ko) 2007-08-27
PL1809652T3 (pl) 2010-10-29
US20090111731A1 (en) 2009-04-30
ATE466867T1 (de) 2010-05-15
WO2006047900A3 (de) 2006-07-27
BRPI0517917B1 (pt) 2020-11-10
US7964630B2 (en) 2011-06-21
CN101061134A (zh) 2007-10-24
CA2584643A1 (en) 2006-05-11
CN101061134B (zh) 2011-05-11
JP2008518978A (ja) 2008-06-05
DE502005009544D1 (de) 2010-06-17
JP5006789B2 (ja) 2012-08-22
WO2006047900A2 (de) 2006-05-11
ES2345667T3 (es) 2010-09-29
EP1809652B1 (de) 2010-05-05
CA2584643C (en) 2013-01-29
BRPI0517917A (pt) 2008-10-21
EP1809652A2 (de) 2007-07-25

Similar Documents

Publication Publication Date Title
KR101227301B1 (ko) 표정을 지을때 생기는 주름 및 노화성 주름에 대한 신규한국소 적용제
EP3256102B1 (en) Peptidic compounds, compositions comprising them and uses of said compounds, in particular cosmetic uses
KR101757946B1 (ko) 근 수축을 억제하는 화합물
US20250019400A1 (en) Polypeptide and cosmetic composition or pharmaceutical composition and use thereof
EP3225620B1 (en) Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition containing same
KR20040062602A (ko) 피부약학적 및 화장품학적 활성 올리고펩타이드
US8722852B2 (en) Cosmetic composition for stimulating the synthesis of proteins of the basement membrane
WO2007087738A1 (de) Biologisch aktive tripeptide, deren kupferkomplexe und salze
CN104478991B (zh) 一种新型多肽化合物及其制备方法和其医药应用
KR101667383B1 (ko) 비오틴이 결합된 ｈｅｘａｐｅｐｔｉｄｅ-２ 유도체 및 이의 용도
US20230399359A1 (en) Tetrapeptides, compositions comprising them, and their cosmetic use
CN104592347A (zh) 一种含有15n—l—脯氨酸残基的三肽减皱化合物及其制备方法和应用
KR101224809B1 (ko) 레티노산 유도체, 이의 제조 방법 및 이를 포함하는 화장품 조성물
WO2015111857A1 (ko) 펩타이드 유도체 및 이를 함유하는 기능성 화장품 조성물
KR20180108988A (ko) 인간 섬유아세포에서 콜라겐 합성 촉진 및 콜라겐 분해 효소 활성화 억제를 유도하는 펩타이드를 함유한 화장품 조성물 및 제조방법
CN104592348A (zh) 一种含有3,4-脱氢-l-脯氨酸残基的三肽减皱化合物及其制备方法和应用
HK1237798B (zh) 稳定的肽缀合抗坏血酸衍生物、用於制备其的方法和包含其的化妆品组合物

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20070515

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20100817

Comment text: Request for Examination of Application

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20110406

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20111215

Patent event code: PE09021S01D

PE0902 Notice of grounds for rejection

Comment text: Final Notice of Reason for Refusal

Patent event date: 20120720

Patent event code: PE09021S02D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20121227

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20130122

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20130122

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20151217

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20151217

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20161220

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20161220

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20171219

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20171219

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20190103

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20190103

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20200103

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20200103

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20210108

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20211215

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20231218

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20241216

Start annual number: 13

End annual number: 13